149 related articles for article (PubMed ID: 21308880)
1. Predictors of fibrostenotic Crohn's disease.
Rieder F; Lawrance IC; Leite A; Sans M
Inflamm Bowel Dis; 2011 Sep; 17(9):2000-7. PubMed ID: 21308880
[TBL] [Abstract][Full Text] [Related]
2. Disease behavior in adult patients: are there predictors for stricture or fistula formation?
Dotan I
Dig Dis; 2009; 27(3):206-11. PubMed ID: 19786742
[TBL] [Abstract][Full Text] [Related]
3. Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's disease.
Brand S
Inflamm Bowel Dis; 2012 Feb; 18(2):393-4. PubMed ID: 22038884
[No Abstract] [Full Text] [Related]
4. Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
Lewis A; Nijhuis A; Mehta S; Kumagai T; Feakins R; Lindsay JO; Silver A
Inflamm Bowel Dis; 2015 May; 21(5):1141-50. PubMed ID: 25636122
[TBL] [Abstract][Full Text] [Related]
5. Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
Bettenworth D; Rieder F
Inflamm Bowel Dis; 2016 Jan; 22(1):241-7. PubMed ID: 26588089
[TBL] [Abstract][Full Text] [Related]
6. How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures.
Govani SM; Stidham RW; Higgins PD
J Crohns Colitis; 2013 Dec; 7(11):923-7. PubMed ID: 23880128
[TBL] [Abstract][Full Text] [Related]
7. Circulating fibrocytes and Crohn's disease.
Sahebally SM; Burke JP; Chang KH; Kiernan MG; O'Connell PR; Coffey JC
Br J Surg; 2013 Nov; 100(12):1549-56. PubMed ID: 24264775
[TBL] [Abstract][Full Text] [Related]
8. Fibrotic Strictures in Crohn's Disease: Mechanisms and Predictive Factors.
Mager R; Roda G; Shalaby MK; Vetrano S
Curr Drug Targets; 2021; 22(2):241-251. PubMed ID: 33081672
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of fibrostenosing Crohn's disease.
Li J; Mao R; Kurada S; Wang J; Lin S; Chandra J; Rieder F
Transl Res; 2019 Jul; 209():39-54. PubMed ID: 30981697
[TBL] [Abstract][Full Text] [Related]
10. Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.
Stidham RW; Wu J; Shi J; Lubman DM; Higgins PD
PLoS One; 2017; 12(1):e0170506. PubMed ID: 28114331
[TBL] [Abstract][Full Text] [Related]
11. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease.
Rieder F; Latella G; Magro F; Yuksel ES; Higgins PD; Di Sabatino A; de Bruyn JR; Rimola J; Brito J; Bettenworth D; van Assche G; Bemelman W; d'Hoore A; Pellino G; Dignass AU
J Crohns Colitis; 2016 Aug; 10(8):873-85. PubMed ID: 26928961
[TBL] [Abstract][Full Text] [Related]
12. The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease.
Fiorino G; Cesarini M; Malesci A; Danese S; Sorrentino D
Curr Drug Targets; 2012 Sep; 13(10):1273-9. PubMed ID: 22664085
[TBL] [Abstract][Full Text] [Related]
13. Fibrostenotic Crohn's disease.
Froehlich F; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Gonvers JJ; Michetti P
Digestion; 2007; 76(2):113-5. PubMed ID: 18239402
[TBL] [Abstract][Full Text] [Related]
14. Obstructive fibrostenotic Crohn's disease.
Froehlich F; Juillerat P; Mottet C; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
Digestion; 2005; 71(1):29-30. PubMed ID: 15711046
[TBL] [Abstract][Full Text] [Related]
15. [Fibrogenesis and inflammatory bowel disease].
Sans M; Masamunt MC
Gastroenterol Hepatol; 2007 Jan; 30(1):36-41. PubMed ID: 17266880
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers of fibrostenotic Crohn's disease: Where are we now?
He JS; Tan JY; Li XZ; Feng R; Xiong SS; Lin SN; Qiu Y; Mao R
J Dig Dis; 2020 Jun; 21(6):336-341. PubMed ID: 32496631
[TBL] [Abstract][Full Text] [Related]
17. Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and strictures.
Meier JK; Scharl M; Miller SN; Brenmoehl J; Hausmann M; Kellermeier S; Schölmerich J; Rogler G
Inflamm Bowel Dis; 2011 Jan; 17(1):202-12. PubMed ID: 20848526
[TBL] [Abstract][Full Text] [Related]
18. [Susceptibility genes and serum markers of intestinal fibrosis in Crohn disease].
Li G; Ren J; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1326-1330. PubMed ID: 29178104
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch.
Shen B; Fazio VW; Remzi FH; Bennett AE; Lavery IC; Lopez R; Brezinski A; Sherman KK; Bambrick ML; Lashner BA
Dis Colon Rectum; 2007 Sep; 50(9):1450-9. PubMed ID: 17665259
[TBL] [Abstract][Full Text] [Related]
20. Targeting anti-fibrotic pathways in Crohn's disease - The final frontier?
Ma C; Jairath V; Click B; Hirota SA; Lu C; Parker CE; Rieder F;
Best Pract Res Clin Gastroenterol; 2019; 38-39():101603. PubMed ID: 31327400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
